Indeed plasma NGAL and low molecular weight proteinuria were significantly increased compared to controls even if biomarkers currently used for diagnosis and risk of AKI (i.e. serum creatinine and estimated glomerular filtration rate (eGFR))26–31 were not altered. This evidence concerns the gene LCN2 and acute kidney injury.